ES2012940A6 - Un procedimiento para la preparacion de una celula de mamifero capaz de expresar interleukin-2 humana. - Google Patents

Un procedimiento para la preparacion de una celula de mamifero capaz de expresar interleukin-2 humana.

Info

Publication number
ES2012940A6
ES2012940A6 ES8804018A ES8804018A ES2012940A6 ES 2012940 A6 ES2012940 A6 ES 2012940A6 ES 8804018 A ES8804018 A ES 8804018A ES 8804018 A ES8804018 A ES 8804018A ES 2012940 A6 ES2012940 A6 ES 2012940A6
Authority
ES
Spain
Prior art keywords
human interleukin
mammalian cells
coding
enhanced expression
mammalian cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8804018A
Other languages
English (en)
Inventor
Cullen Bryan Richard Ricard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES2012940A6 publication Critical patent/ES2012940A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UN PROCEDIMIENTO PARA LA PREPARACION DE UNA CELULA DE MAMIFERO CAPAZ DE EXPRESAR INTERLEUKIN-2 HUMANA, CUYO PROCEDIMIENTO COMPRENDE TRANSFERIR UNA CELULA DE MAMIFERO CONTENIENDO UN VECTOR RECOMBINANTE QUE COMPRENDE UN VECTOR Y UNA SECUENCIA DE DNA QUE CODIFICA LA INTERLEUKIN-2 HUMANA Y UNA SECUENCIA DE PEPTIDOS SEÑALIZADORA QUE COMPRENDE DE UN GEN QUE CODIFICA LA INTERLEUKIN-2 HUMANA Y UNA SECUENCIA DE PEPTIDOS SEÑALIZADORA EN EL QUE LAS SECUENCIAS NO CODIFICADORAS EN 5'' DEL GEN HAN SIDO SUSTITUIDAS POR SECUENCIAS HETEROLOGAS NO CODIFICADORAS EN 5''. LA INTERLEUKIN-2 HUMANA PUEDE UTILIZARSE COMO COMPUESTO INMUNOMODULADOR PARA EL TRATAMIENTO Y PREVENCION DE ENFERMEDADES.
ES8804018A 1986-05-12 1988-12-30 Un procedimiento para la preparacion de una celula de mamifero capaz de expresar interleukin-2 humana. Expired - Lifetime ES2012940A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/862,082 US4992367A (en) 1986-05-12 1986-05-12 Enhanced expression of human interleukin-2 in mammalian cells

Publications (1)

Publication Number Publication Date
ES2012940A6 true ES2012940A6 (es) 1990-04-16

Family

ID=25337602

Family Applications (2)

Application Number Title Priority Date Filing Date
ES8701394A Expired ES2006476A6 (es) 1986-05-12 1987-05-11 Un procedimiento para obtener interleukin-2 humana
ES8804018A Expired - Lifetime ES2012940A6 (es) 1986-05-12 1988-12-30 Un procedimiento para la preparacion de una celula de mamifero capaz de expresar interleukin-2 humana.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES8701394A Expired ES2006476A6 (es) 1986-05-12 1987-05-11 Un procedimiento para obtener interleukin-2 humana

Country Status (25)

Country Link
US (1) US4992367A (es)
JP (1) JPS62278994A (es)
AR (1) AR241794A1 (es)
AT (1) AT389892B (es)
AU (1) AU603576B2 (es)
BE (1) BE1000717A5 (es)
CH (1) CH675731A5 (es)
DE (1) DE3715808A1 (es)
DK (1) DK234087A (es)
ES (2) ES2006476A6 (es)
FI (1) FI872096A7 (es)
FR (1) FR2598433B1 (es)
GB (1) GB2190382B (es)
GR (1) GR870727B (es)
HU (1) HU205384B (es)
IL (1) IL82475A0 (es)
IT (1) IT1215478B (es)
LU (1) LU86874A1 (es)
MC (1) MC1821A1 (es)
NL (1) NL8701132A (es)
NO (1) NO871939L (es)
NZ (1) NZ220246A (es)
PT (1) PT84849B (es)
SE (1) SE8701934L (es)
ZA (1) ZA872768B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3014099B2 (ja) * 1987-08-26 2000-02-28 バイオジェン インコーポレイテッド 生物的材料、生物的材料の生産およびこの種の材料の治療への使用方法
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices
FR2636231A1 (fr) * 1988-09-09 1990-03-16 Sanofi Sa Cellules eucaryotes recombinees productrices d'interleukine-1 (beta) mature n-glycosylee, procede et vecteurs necessaires pour leur obtention et procede d'obtention d'interleukine-1 (beta) mature n-glycosylee
WO1990010069A1 (fr) * 1989-02-28 1990-09-07 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr ADN pAA 1213-23 ET pAC 262-33 DE PLASMIDE DE RECOMBINAISON CODANT POUR LA SYNTHESE D'INTERLEUKINE-2 HUMAINE, LEUR PROCEDE DE CONSTRUCTION ET SOUCHE DE BACTERIES ESCHERICHIA COLI RRI/pAC 262-33 EN TANT QUE PRODUCTEUR D'INTERLEUKINE-2 HUMAINE
IL95330A0 (en) * 1989-08-11 1991-06-30 Lilly Co Eli Expression of a functional insect specific toxin gene in mammalian cells
GB9106185D0 (en) * 1991-03-22 1991-05-08 Wellcome Found Biological control agents
US5548075A (en) * 1993-08-30 1996-08-20 Utah State University DNA cassette and transgenic organisms carrying lytic peptide-encoding genes
US5856178A (en) * 1993-08-30 1999-01-05 Utah State University DNA cassettes for expression of lytic peptides in mammalian cells and transgenic organisms containing same
US5641665A (en) * 1994-11-28 1997-06-24 Vical Incorporated Plasmids suitable for IL-2 expression
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
CA2231603C (en) 1995-10-17 2009-04-21 Wayne State University Chicken interleukin-15 and uses thereof
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
AUPP655698A0 (en) 1998-10-16 1998-11-05 Commonwealth Scientific And Industrial Research Organisation Delivery system for porcine somatotropin
US20070025958A1 (en) 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
KR20020043448A (ko) * 2000-12-04 2002-06-10 리송알렉스인근 인터루킨-2 재조합 단백질 및 그의 제조방법
US20040071671A1 (en) * 2001-02-20 2004-04-15 Leturcq Didier J. Cell therapy method for the treatment of tumors
WO2002065992A2 (en) * 2001-02-20 2002-08-29 Ortho-Mcneil Pharmaceutical, Inc. A cell therapy method for the treatment of tumors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2814039C3 (de) * 1978-03-31 1981-02-19 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig Verfahren zur Herstellung von Hybrid-Bakterien
US4405712A (en) * 1981-07-01 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services LTR-Vectors
EP0091539B2 (en) * 1982-03-31 1996-11-27 Ajinomoto Co., Inc. Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells
AU556353B2 (en) * 1982-12-15 1986-10-30 Ajinomoto Co., Inc. Interleukin-2 polypeptide
AU579089B2 (en) * 1983-02-08 1988-11-17 Biogen, Inc. Human interleukin-2-like polypeptides
EP0119621A1 (en) * 1983-03-21 1984-09-26 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Interleukin-2
WO1985000817A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of interleukin ii
GB8327880D0 (en) * 1983-10-18 1983-11-16 Ajinomoto Kk Saccharomyces cerevisiae
EP0162898A4 (en) * 1983-11-14 1987-07-23 Chiron Corp INTERLEUKIN-2 GENERATION USING CLONED GENES FOR INTERLEUKIN-2 AND YEAR ALPHA FACTOR.
FR2559782B1 (fr) * 1984-02-16 1986-07-18 Transgene Sa Vecteur d'expression dans les levures de l'interleukine-2, levures transformees et procede de preparation de l'interleukine-2
EP0163603B1 (en) * 1984-05-08 1989-12-13 Genetics Institute, Inc. A human t-cell growth factor
DE3419995A1 (de) * 1984-05-29 1985-12-05 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens
EP0172619A1 (en) * 1984-06-20 1986-02-26 Takeda Chemical Industries, Ltd. Novel transformant and use thereof
CA1275954C (en) * 1984-08-31 1990-11-06 Hing Cheug Wong 3'-expression enhancing fragments and method
FR2583770B1 (fr) * 1985-06-21 1988-08-19 Transgene Sa Expression de l'il-2 humaine dans les cellules de mammiferes par un poxvirus recombine
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices

Also Published As

Publication number Publication date
DE3715808A1 (de) 1987-12-10
FR2598433B1 (fr) 1990-09-21
JPS62278994A (ja) 1987-12-03
AT389892B (de) 1990-02-12
HUT45558A (en) 1988-07-28
PT84849B (pt) 1990-02-08
US4992367A (en) 1991-02-12
MC1821A1 (fr) 1988-03-18
HU205384B (en) 1992-04-28
NO871939D0 (no) 1987-05-11
ATA263787A (de) 1989-07-15
BE1000717A5 (fr) 1989-03-21
NZ220246A (en) 1990-07-26
PT84849A (pt) 1987-06-01
ZA872768B (en) 1988-04-27
NL8701132A (nl) 1987-12-01
AR241794A1 (es) 1992-12-30
FI872096A0 (fi) 1987-05-12
GB2190382A (en) 1987-11-18
FI872096A7 (fi) 1987-11-13
AU7270387A (en) 1987-11-19
DK234087D0 (da) 1987-05-08
GR870727B (en) 1987-09-21
LU86874A1 (fr) 1988-06-13
ES2006476A6 (es) 1989-05-01
GB8711072D0 (en) 1987-06-17
AU603576B2 (en) 1990-11-22
SE8701934L (sv) 1987-11-13
IT8720479A0 (it) 1987-05-12
SE8701934D0 (sv) 1987-05-11
IL82475A0 (en) 1987-11-30
NO871939L (no) 1987-11-13
CH675731A5 (es) 1990-10-31
IT1215478B (it) 1990-02-14
FR2598433A1 (fr) 1987-11-13
GB2190382B (en) 1990-08-15
DK234087A (da) 1987-11-13

Similar Documents

Publication Publication Date Title
ATE192500T1 (de) Rekombinante viren vektoren zur expression in muskelzellen
ATE319827T1 (de) Polypeptid, das die differenzierung unterdrueckt
AR241314A1 (es) Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional.
AR241654A1 (es) Procedimiento para producir activador de plasminogeno de tejido humano.
PT97316A (pt) Sequencias de dna,construcoes de dna e metodo para a sua aplicacao no tratamento de doencas celulares proliferativas
ES8701226A1 (es) Procedimiento de obtencion de una proteina de factor estimu-lante de colonias (csf) en primates
GT198277746A (es) Interteron inmune humano
ES2054638T3 (es) Gen codificante de los factores humanos de estimulacion colonial.
ES2006476A6 (es) Un procedimiento para obtener interleukin-2 humana
ES8506089A1 (es) Un procedimiento para preparar una celula u organismo recombinante
ES8500325A1 (es) Procedimiento para la preparacion de proteinas funcionales de uroquinasa humana.
IL64243A (en) Hybrid human leukocyte interferon type anti-viral polypeptides,their preparation by genetic engineering methods and pharmaceutical compositions containing them
RU98120519A (ru) Аутоантиген и структурно-родственные ему белки для применения при иммунотерапии аутоиммунных заболеваний
MD960317A (ro) Noile peptide-agoniste ale amilinei şi utilizarea lor
ES2051830T3 (es) Solucion acuosa estable de anticuerpos.
AR002742A1 (es) Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
ES2066237T3 (es) Procedimiento para producir gamma-interferon humano recombinante sin cisteina carente de metionina en el extremo n-terminal.
ES2059330T3 (es) Un cdna codificador de antigeno carcinoembrionico.
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
ES8707554A1 (es) Procedimiento para preparar interferon-a recombinante
ES2061850T3 (es) Virus recombinante de la enfermedad de marek, su procedimiento de preparacion y vacuna.
IL75553A (en) Dna sequence coding for a cholinesterase-like peptide, peptides produced by cells containing said dna and antibodies thereto
ES8506092A1 (es) Un metodo de producir un precursor del factor de liberacion de la hormona del crecimiento humana
HUP0001057A2 (hu) A szarvasmarhafélék laktációjával összefüggő fehérje (CD14), az azt kódoló gén és a fehérje B-sejt-aktiválásban való alkalmazása
ES8504248A1 (es) Procedimiento para la fabricacion de un plasmido recombinante que contiene un aminoacido

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000301